Exciting news in the world of sustainable investing as Radiant AI, a cutting-edge technology company focused on empowering ESG advisors and consultants with faster assessments and analysis, announces a significant funding milestone. The company has successfully raised an impressive $600,000,000 in its latest round of funding. This substantial amount will be utilized to further develop Radiant AI's innovative platform, enhancing its capabilities and expanding its reach within the ESG sector. With a mission to provide advanced tools and insights to help businesses make more informed decisions regarding environmental, social, and governance factors, Radiant AI is poised to revolutionize the way sustainability is integrated into investment strategies. This funding injection will undoubtedly propel the company towards even greater success and impact in the realm of sustainable finance.
Radiant AI Secures $600 Million in Funding to Revolutionize ESG Advisory Services
Recently funded · €600.0MTechnology, Information and Internet
Get the full Radiant AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
